Free Access
| Issue |
Med Sci (Paris)
Volume 27, Number 3, Mars 2011
|
|
|---|---|---|
| Page(s) | 249 - 251 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/2011273249 | |
| Published online | 30 March 2011 | |
- TorresVE, HarrisPC.. Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int 2009 ; 76 : 149-168. [CrossRef] [PubMed] [Google Scholar]
- LeuenrothSJ, OkuharaD, ShotwellJD, et al. Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease. Proc Natl Acad Sci USA 2007 ; 104 : 4389-4394. [CrossRef] [Google Scholar]
- WangX, WuY, WardCJ, et al. Vasopressin directly regulates cyst growth in polycystic kidney disease. Am Soc Nephrol 2008 ; 19 : 102-108. [CrossRef] [Google Scholar]
- Van KeimpemaL, NevensF, VanslembrouckR, et al. Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial. Gastroenterology 2009 ; 137 : 1661-1668. [CrossRef] [PubMed] [Google Scholar]
- ShillingfordJM, MurciaNS, LarsonCH, et al. The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc Natl Acad Sci USA 2006 ; 103 : 5466-5471. [CrossRef] [Google Scholar]
- WalzG, BuddeK, MannaaM, et al. Everolimus in patients with autosomal dominant polycystic kidney disease. Engl J Med 2010 ; 363 : 830-840. [CrossRef] [Google Scholar]
- SerraAL, PosterD, KistlerAD, et al. Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. Engl J Med 2010 ; 363 : 820-829. [CrossRef] [Google Scholar]
- CanaudG, KnebelmannB, HarrisPC, et al. Therapeutic mTOR inhibition in autosomal dominant polycystic kidney disease: what is the appropriate serum level?. Am J Transplant 2010 ; 10 : 1701-1706. [CrossRef] [PubMed] [Google Scholar]
- PalletN, BeauneP, ThervetE, et al. Inhibiteurs de mTOR : des antiprolifératifs pléiotropiques. Med Sci (Paris) 2006 ; 22 : 947-952. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.